Every meaningful advance in treatment has been the result of a clinical trial
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group mission is to improve treatments and outcomes for people affected by Below the Belt cancers.
Find out more
Poor outcomes from advanced prostate cancer can be reversed with targeted treatment
New research findings of the ENZAMET (ANZUP 1304) study, reveal that people who inherit a genetic biomarker known to predict poorer outcomes with routine prostate cancer treatment, can be successfully treated and have better survival outcomes with personalised hormonal therapy for advanced prostate cancer.
Find Out More
LuPSMA shows promise as first-line treatment for prostate cancer
Lutetium-177 PSMA-617 – or LuPSMA – therapy had been shown in previous clinical trials to extend lives, and improve quality-of-life, in patients with advanced metastatic prostate cancers who have exhausted all other treatment options. The UpFrontPSMA (ANZUP 1904) study was the first to test this treatment in patients with newly diagnosed prostate cancers that had spread.
Find Out More
ANZUP x Sydney Sock Project
That’s right, we have partnered up with the Sydney Sock Project to design and produce a variety of cheeky socks. Say hello to the ‘Penis Sock’ ‘Testicle Sock’ and ‘Below the Belt Sock’.
Grab a Pair
Previous slide
Next slide
0
Trials
0 +

Sites

0 +

Patients Enrolled

0

Countries

ANZUP Cancer, ANZUP

What we do

ANZUP is the leading cancer cooperative clinical trials group that brings together all of the professional disciplines and groups involved in researching and treating below the belt (penile, bladder, kidney, prostate and testicular) cancers and conduct high quality clinical research.

ANZUP identifies gaps in evidence and areas of clinical need, collaborates with the leading clinicians and researchers in below the belt cancers, and communicate frequently and effectively with the broader community along the way.
ANZUP Cancer, ANZUP

Join ANZUP

If you are not yet an ANZUP member then join our large
multidisciplinary network of urogenital and prostate cancer
researchers, clinicians, nurses, psychologists, scientists, allied
health and consumer representatives. Membership is free.

If you are a member of the community and would like to learn more about below the belt cancers, then join ‘Friends of ANZUP’.

ANZUP Cancer, ANZUP

Trials and Research

All of the major milestones in controlling cancer worldwide have
come through clinical trials, but we still have a long way to go to
help every person affected, at risk or diagnosed with this disease.
We have clinical trials across each cancer type, in various stages
of progress: in activation, open to patient recruitment, in follow
up and completed trials.

Telehealth and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations.

Teleheath and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations, or in self-isolation due to COVID-19. Teletrials also allows trials recruitment and activity to continue.

Very excited to announce a land-mark new partnership between @ANZUPTrials & @PCFA which will accelerate research to improve the lives of Australian’s with #prostatecancer! Thanks to the generosity of the community to enable this partnership! @Prof_IanD https://ow.ly/Pihe50TJjJ6

2

This is your last chance to register for this great learning opportunity, full of insightful discussion and informative collaboration around clinical trials. https://anzup.org.au/bp-masterclass/
Share this post with someone who might be interested or could benefit from this event!

Our 2024 Masterclass speakers are looking forward to sharing their expert knowledge with you throughout this collaborative and insightful program. Join us and learn from the very best!
Applications close next Friday October 11, don't miss out! https://anzup.org.au/bp-masterclass/

Congrats to Study Chair @DrBenTran & the team for recruiting their 150th patient (by site PI Dr Orlaith Heron at @HNZSouthern - Dunedin Hospital) on the @ANZUPtrials #TesticularCancer translational study #CLIMATE - reaching 75% recruitment! @WEHI_research @ciaraconduit @Prof_IanD

Load More

Latest News